MedTrace Logo

To Assess the Efficacy of CitruSlim® on Body Composition as Well as Metabolic and Hormonal Factors in Overweight and Obese Individuals

NCT03973086 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 97

Last updated 2021-04-12

No results posted yet for this study

Summary

CitruSlim® can promote healthy weight loss by promoting anabolic state during weight loss programs, prevent the body from storing fat, reduce appetites and maintain healthy cholesterol and blood glucose level during weight loss program.

This study focuses to prove the efficacy and safety of the product in a population of overweight and obese individual.

Conditions

  • Overweight and Obesity

Interventions

DIETARY_SUPPLEMENT

Citrus flavonone-O-glycosides- LD

Low Dose of 200 mg

DIETARY_SUPPLEMENT

Citrus flavonone-O-glycosides- HD

High Dose of 400 mg

DIETARY_SUPPLEMENT

Placebo

Placebo (Microcrystalline Cellulose) of 400 mg

Sponsors & Collaborators

  • Vedic Lifesciences Pvt. Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-04
Primary Completion
2020-05-30
Completion
2020-09-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03973086 on ClinicalTrials.gov